Studies in mouse models demonstrate that homozygous inactivation of SMARCB1 is embryonically lethal, although induced somatic homozygous loss results in the rapid onset of cancer in 100% of mice at 11 weeks [75–77]. This evidence concerns the gene SMARCB1 and cancer.